Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Pityriasis rosea during etanercept therapy.
Eur Rev Med Pharmacol Sci
January 2010
Department of Social Territorial Medicine, Section of Dermatology, University of Messina, Italy.
Multiple bioengineered agents has been recently developed to attack other parts of the immune/inflammatory system, achieving therapeutic implications for dermatologic diseases. On the other side, each new therapy has the potential for adverse cutaneous reactions. We present herein the first two cases of Gibert's pityriasis rosea occurring during etanercept therapy and discuss possible links between this common, etiologically still unexplained exanthema and anti-tumor necrosis factor-alpha drugs.
View Article and Find Full Text PDF[Histopathologic, ultrastructural, immunologic and virologic study of Gibert's pityriasis rosea].
Ann Dermatol Venereol
June 1983
A complete study of pityriasis rosea (Gibert) has been performed; this study includes: --a pathological and ultrastructural examination of the skin biopsies; --an immunological study: direct and indirect immunofluorescence (seric anti-cutaneous antibodies); --a virological investigation: ultrastructural examination of the specimens, inoculation of homogenized-skin specimens to 3 cellular cultures; --serological investigations for influenza A, B, parainfluenza 1, 2, 3, adenovirus, respiratory syncitial virus, Mycoplasma pneumoniae, ornithosis-psittacosis, Q-fever, herpes-virus, herpes-virus varicellae, cytomegalovirus, Epstein-Barr virus. All viral investigations had a negative result. Virus or virus-like particle has were not detected on the ultrastructural examinations.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!